{
    "symbol": "SEM",
    "quarter": 4,
    "year": 2022,
    "date": "2023-02-24 14:52:05",
    "content": " Our outpatient rehabilitation division surpassed prior year revenue for the quarter, but did experienced elevated cost margins in labor and other operating expenses compared to Q4 prior year. Overall, when compared to prior year Q4 we experienced revenue growth of 1.4% and a 7.6% increase in adjusted EBITDA. For the quarter, total company adjusted EBITDA was $148.9 million compared to $138.4 million in the prior year. Our critical illness recovery hospital division, adjusted EBITDA margin was 8% for the quarter compared to 4% in prior year Q4 and 2% in Q3 of 2022. Revenue decreased 3% compared to prior year quarter, primarily related to volume, occupancy decreased from 71% to 70%, while our revenue per patient day remained consistent compared to prior year. Our outpatient rehabilitation division experienced an increase of 1% in net revenue with patient volumes, increasing by 3% compared to same quarter prior year. Earnings per fully-diluted share were $0.22 in the fourth quarter compared to $0.37 per share in the same quarter prior year, prior year Q4 had a tax benefit-related to our purchase of centers remaining membership interest along with lower interest expense on our debt, which had a positive impact on Q4 prior year EPS. In Q4, equity in earnings unconsolidated subsidiaries were $6.8 million, this compares to $11.2 million in the same quarter prior year, primarily decline in earnings was the result of decreased earnings of a few of our unconsolidated joint-ventures."
}